BFM
ACAD icon

Boothbay Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Boothbay Fund Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-786,800
Closed -$13.1M – 1418
2025
Q1 		$13.1M Buy
+786,800
New +$14.3M 0.45% 45
2024
Q2 		– Sell
-212,100
Closed -$3.92M – 1480
2024
Q1 		$3.92M Buy
+212,100
New +$5.25M 0.11% 303
2023
Q4 		– Sell
-134,400
Closed -$2.8M – 1616
2023
Q3 		$2.8M Buy
+134,400
New +$3.65M 0.09% 382
2020
Q2 		– Sell
-206
Closed -$870K – 939
2020
Q1 		$870K Buy
+206
New +$8.49K 0.09% 332

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return